Becton Dickinson (BDX) Unveils Advanced Cell Analyzer

Author's Avatar
May 13, 2025
Article's Main Image

Key Highlights:

  • Becton, Dickinson and Company introduces groundbreaking cell analyzer with BD SpectralFX Technology, enhancing flow cytometry capabilities.
  • Analysts project a one-year average price target of $220.29 for BDX, suggesting a potential 25.64% upside from current levels.
  • BDX's GF Value estimation indicates a possible 59.56% uptick, highlighting the stock's potential undervaluation.

BDX's Innovative Breakthrough in Cell Analysis

Becton, Dickinson and Company (BDX, Financial) has globally launched a cutting-edge cell analyzer that integrates revolutionary spectral and real-time cell imaging technologies. This innovation, known as BD SpectralFX Technology, considerably elevates the field of flow cytometry by allowing for the simultaneous examination of over 50 cell characteristics. Such advancements are poised to significantly bolster advanced biomarker discovery efforts, presenting substantial implications for the future of biotechnology research and development.

Wall Street's Perspective: Price Targets and Recommendations

1922275891883438080.png

Wall Street analysts have set a one-year price target for Becton Dickinson & Co (BDX, Financial) at an average of $220.29. Projections range with a high estimate of $321.50 and a low estimate of $172.00, suggesting a 25.64% potential upside from the latest price of $175.34. For further insight into these projections, visit the detailed Becton Dickinson & Co (BDX) Forecast page.

Analysts' Consensus: Outperform Rating

Seventeen brokerage firms have weighed in on BDX, culminating in an average brokerage recommendation of 2.4. This rating designates BDX as an "Outperform" candidate, using a scale where 1 indicates a Strong Buy and 5 denotes a Sell.

BDX's GF Value: Assessing Fair Market Value

According to GuruFocus estimates, the GF Value for Becton Dickinson & Co (BDX, Financial) in one year is projected at $279.77. This suggests a significant 59.56% potential increase from the current trading price of $175.34. The GF Value metric offers an estimate of the stock's fair value, computed through a combination of historical trading multiples, past business growth trajectories, and projected business performance. For a comprehensive analysis, please refer to the Becton Dickinson & Co (BDX) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.